Peptides DB
Research-centric peptide and protocol reference hub
Study 1 of 1Vilon (KE) literaturePubMed · Observational · Preclinical2022

Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line.

The study suggests that Khavinson peptides may influence inflammatory responses in monocytes and macrophages, but further research is needed to confirm these effects in vivo.

Read at PubMedAdd to compare

Where it sits

this study against the rest of the vilon (ke) corpus
0
Preclinical
1
Observational · this one
0
Open-label
0
Randomised
0
Reviews

Summary and findings

This study evaluates the effects of five peptides, including Vilon, on inflammatory and proliferative processes in the THP-1 cell line. The peptides were tested for their capacity to modulate key proliferative patterns and cytokine expression in vitro. The findings suggest that these peptides can influence monocyte and macrophage activity.

How much of this paper we could read: full text read (0.70). We had a clear abstract, so the summary below closely tracks the paper. What this means →
Not reported in abstract.Preclinical2022

Abstract

The authors’ words, as PubMed supplied them

This study evaluates the effects of five different peptides, the Epitalon<sup>®</sup> tetrapeptide, the Vilon<sup>®</sup> dipeptide, the Thymogen<sup>®</sup> dipeptide, the Thymalin<sup>®</sup> peptide complex, and the Chonluten<sup>®</sup> tripeptide, as regulators of inflammatory and proliferative processes in the human monocytic THP-1, which is a human leukemia monocytic cell line capable of differentiating into macrophages by PMA in vitro. These peptides (Khavinson Peptides<sup>®</sup>), characterized by Prof. Khavinson from 1973 onwards, were initially isolated from animal tissues and found to be organ specific. We tested the capacity of the five peptides to influence cell cultures in vitro by incubating THP-1 cells with peptides at certain concentrations known for being effective on recipient cells in culture. We found that all five peptides can modulate key proliferative patterns, increasing tyrosine phosphorylation of mitogen-activated cytoplasmic kinases. In addition, the Chonluten tripeptide, derived from bronchial epithelial cells, inhibited in vitro tumor necrosis factor (TNF) production of monocytes exposed to pro-inflammatory bacterial lipopolysaccharide (LPS). The low TNF release by monocytes is linked to a documented mechanism of TNF tolerance, promoting attenuation of inflammatory action. Therefore, all peptides inhibited the expression of TNF and pro-inflammatory IL-6 cytokine stimulated by LPS on terminally differentiated THP-1 cells. Lastly, by incubating the THP1 cells, treated with the peptides, on a layer of activated endothelial cells (HUVECs activated by LPS), we observed a reduction in cell adhesion, a typical pro-inflammatory mechanism. Overall, the results suggest that the Khavinson Peptides<sup>®</sup> cooperate as natural inducers of TNF tolerance in monocyte, and act on macrophages as anti-inflammatory molecules during inflammatory and microbial-mediated activity.

Background

The paper addresses the role of peptides in modulating immune responses, particularly focusing on monocyte and macrophage activity. Prior research has established that these cells play a crucial role in inflammation and tissue homeostasis. Understanding how peptides like Vilon (KE) affect these pathways is essential for potential therapeutic applications.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Key findings

  • Not reported in abstract.

Limitations

  • Not reported in abstract.